Skip to content
  • Wednesday, 17 June 2026
  • 10:02 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Vedana Therapeutics Secures $46 Million Series A to Advance Next-Generation Migraine Prevention Therapies Targeting PACAP
Pharmaceutical R&D

Vedana Therapeutics Secures $46 Million Series A to Advance Next-Generation Migraine Prevention Therapies Targeting PACAP

Teuku Ryan Jun 17, 2026 0

Seattle-based biotech firm Vedana Therapeutics has successfully closed a $46 million Series A financing round, a significant infusion of capital…

Read More
Beyond the silver bullet: Why precision medicine is the next frontier for the $1 trillion obesity marketMoving beyond the binary: how the convergence of small and large molecules is reshaping pharmaceutical R&DOne Whale Song Unlocks Oceans of Data, Revolutionizing Marine Species DetectionJAMA study finds moderate caffeine intake tracks with lower dementia risk, provides adenosine-pathway nudge for drug hunters
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Takara Bio Unveils Benchmarking Study Comparing Trekker FX with Visium HD and Xenium 5K for Spatial Transcriptomics in FFPE TissuesTop pharma companies set sustainability goals, but emissions are still increasing.Vedana Therapeutics Secures $46 Million Series A to Advance Next-Generation Migraine Prevention Therapies Targeting PACAPDeveloper Chronicles Journey of Building Bespoke AI Assistant, Citing Enhanced Productivity and Data Sovereignty
YOU MAY HAVE MISSED
Biotech & Genetic Research
Takara Bio Unveils Benchmarking Study Comparing Trekker FX with Visium HD and Xenium 5K for Spatial Transcriptomics in FFPE Tissues
Jia Lissa Jun 17, 2026
Laboratory Automation & Robotics
Top pharma companies set sustainability goals, but emissions are still increasing.
Lana Keisha Jun 17, 2026
Pharmaceutical R&D
Vedana Therapeutics Secures $46 Million Series A to Advance Next-Generation Migraine Prevention Therapies Targeting PACAP
Teuku Ryan Jun 17, 2026
Data Science & Bioinformatics
Developer Chronicles Journey of Building Bespoke AI Assistant, Citing Enhanced Productivity and Data Sovereignty
Evan Lee Salim Jun 17, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ